Wakamoto Pharmaceutical Co., Ltd.'s market cap is currently ¥10.27B. The company's EPS TTM is ¥-3.12; its P/E ratio is 159.96; and it has a dividend yield of 1.01%. Wakamoto Pharmaceutical Co., Ltd. is scheduled to report earnings on August 1, 2025, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24
Dec 23
Dec 22
Dec 21
Dec 20
Currency in JPY
Wakamoto Pharmaceutical Co., Ltd. Earnings and Revenue History
